NYSE:BSXMedical Equipment
The Bull Case For Boston Scientific (BSX) Could Change Following Global Recall Of CRE Endoscopy Devices
In May 2026, Boston Scientific voluntarily began recalling multiple CRE and CRE Pro Wireguided endoscopy devices worldwide, after identifying potential sterile breaches in the packaging of tens of thousands of Class II–classified units, with the US FDA now listing the recalls as ongoing.
The concentration of recalls across several size ranges of the same product family highlights how a single packaging issue can ripple through Boston Scientific’s global supply chain, regulatory workload, and...